Aginko Research

Aginko Research AG is a specialized, osteoarticular-focused Contract Research Organization (CRO) based in Lausanne, Switzerland. It offers end-to-end services from preclinical disease modeling and laboratory analysis to full clinical trial operations, including protocol design, patient recruitment, and monitoring. The company positions itself as a niche player with deep expertise in bone, cartilage, and inflammation research, aiming to reduce development time and cost for its clients. As a private service provider, its business model is built on fee-for-service contracts with industry sponsors.

Integrated preclinical and clinical research service platform specializing in osteoarticular and inflammatory diseases. Includes validated disease models, biomechanical testing, specialized histology (hard/soft tissue), biomarker assays, imaging (microCT, MRI), and full clinical trial operations with niche expertise in protocol design and patient recruitment for musculoskeletal studies.

Aginko competes in the crowded CRO market, primarily against large, full-service players (e.g., IQVIA, LabCorp) and other niche, specialty CROs. Its differentiation is its deep, vertical focus on osteoarticular and inflammatory diseases, offering integrated preclinical and clinical services that generalists may lack. Success depends on outperforming competitors in quality, expertise, and client service within this narrow field.